Stella Diagnostics Inc.
SLDX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17,269 | $9,990 | $13,210 | $38,546 |
| - Cash | $5 | $8 | $1 | $1 |
| + Debt | $6,643 | $6,201 | $7,955 | $7,042 |
| Enterprise Value | $23,907 | $16,183 | $21,164 | $45,587 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,236 | -$5,540 | -$5,101 | -$16,100 |
| % Margin | – | – | – | – |
| Net Income | -$1,236 | -$5,707 | -$5,641 | -$16,641 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.019 | -0.034 | -0.17 |
| % Growth | 83.7% | 44.4% | 79.9% | – |
| Operating Cash Flow | -$58 | -$1,677 | -$268 | -$355 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$58 | -$1,677 | -$268 | -$355 |